Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Revel RX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Revel RX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 110 · Grade C

Revel RX

Visit Revel RX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Revel RX a bad call — it's best for readers comparing advertised monthly prices who can confirm their first and recurring charges. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
83
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
84
Track Record
88
78
CoreAge RxBrief Score 94 · 74Revel RX

Price, coverage & the tracker

CoreAge RxRevel RX
Brief Score94/100 (A)74/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Compounded semaglutide advertised at $89/mo. Confirm first charge and refill interval.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Compounded tirzepatide advertised at $155/mo. Confirm first charge and refill interval.

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability for your state and prescription.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Revel RX: Advertised prices have no membership fee. Confirm billing dates and the first charge.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.